Low-molecular-weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement

Thrombosis Research
J A Heit

Abstract

Venous thromboembolism is a major health problem. In about 20% of cases, the initial clinical manifestation of venous thromboembolism is sudden death due to pulmonary embolism. Consequently, appropriate prophylaxis is critical in order to improve survival. Because patients with recent surgery have a 22-fold increased risk of postoperative venous thromboembolism, a large research effort has been directed toward identifying the safest and most effective prophylaxis after surgery, especially after total hip or knee replacement. While low-molecular-weight heparin is the most effective prophylaxis currently available, from 15% to 30% of hip or knee replacement patients still develop deep vein thrombosis by the time of hospital discharge, and another 25% develop new deep vein thrombosis by 3 weeks after discharge. Extended out-of-hospital low-molecular-weight heparin prophylaxis can safely reduce the prevalence of deep vein thrombosis by about 50%. However, essentially all of these thrombi are small, asymptomatic, and resolve without serious clinical sequelae. Based on one clinical trial, out-of-hospital low-molecular-weight heparin prophylaxis could reduce the incidence of symptomatic venous thromboembolism or all-cause death after ...Continue Reading

Associated Clinical Trials

References

Oct 18, 1979·The New England Journal of Medicine·R HullP Armstrong
Nov 19, 1992·The New England Journal of Medicine·D P BrandjesJ W ten Cate
Aug 1, 1983·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P E TreffersG J Kloosterman
Dec 1, 1994·Acta Orthopaedica Scandinavica·M A McNallyR A Mollan
Aug 1, 1996·The Journal of Arthroplasty·D WarwickG Bannister
Mar 14, 1998·Annals of Internal Medicine·L Chasan-Taber, M J Stampfer
Jul 29, 1998·Archives of Internal Medicine·R H WhiteW Bargar

❮ Previous
Next ❯

Citations

Nov 12, 2003·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·S BrambillaS Caserta
Jun 10, 2005·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Omer A IlahiIbrahim Ahmad
Mar 3, 2009·The Spine Journal : Official Journal of the North American Spine Society·Avraam PloumisAlexander R Vaccaro
Nov 13, 2008·Current Problems in Cardiology·Michael D Faulx, Gary S Francis
Feb 27, 2007·São Paulo Medical Journal = Revista Paulista De Medicina·Winston Bonetti YoshidaFrancisco Humberto de Abreu Maffei
Dec 19, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·David Warwick, Nadia Rosencher
Oct 12, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ola E DahlJoakim J Aanesen
Sep 27, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Patrick TilleulYves Ozier
May 12, 2005·The Annals of Pharmacotherapy·Jeremy J Enyart, Ronald J Jones
Dec 22, 2004·International Journal of Technology Assessment in Health Care·James MuntzMatthias Egger
Feb 1, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·A Encke, S Haas
Oct 1, 2011·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·T O SmithC B Hing
Jun 12, 2004·Blood·Jack HirshJeffrey I Weitz
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Feb 22, 2003·American Journal of Physical Medicine & Rehabilitation·Mark V RagucciJoseph Fetto
Jul 10, 2003·The Journal of Bone and Joint Surgery. American Volume·Roman RadlReinhard Windhager
Aug 28, 2003·Journal of Thrombosis and Haemostasis : JTH·D R AbendscheinJ Morser
Sep 8, 2005·Annales Françaises D'anesthèsie Et De Rèanimation·P MismettiP Nertl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.